National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 9) (PB 92 of 2015) (Cth)

PB 92 of 2015

National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 9)

_____________________________________________________________________

I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated    24 September          2015

KYLIE JONASSON

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 9).

(2)This Instrument may also be cited as PB 92 of 2015.

2              Commencement  

This instrument commences on 1 October 2015.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 4, after entry for Timolol in the form Eye drops (gellan gum solution)
   5 mg (as maleate) per mL, 2.5 mL

insert:

Tiotropium Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations)